Variability in body mass index (BMI) during adjuvant chemotherapy is associated with clinical outcomes among invasive ovarian cancer patients

Autor: Starbuck, K., Cannioto, R.A., Etter, J.L., Moysich, K.B., Duncan, W., Morrell, K., Almohanna, H., Joseph, J.M., Szender, J.B., Zsiros, E., Odunsi, K., Frederick, P.J., Lele, S.B., Akers, S.N., Eng, K.H.
Zdroj: In Gynecologic Oncology June 2018 149 Supplement 1:214-215
Databáze: ScienceDirect
Externí odkaz: